These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Studies of the survival-time of Cr51 tagged platelets in healthy subjects and in thrombocytopenia]. Pawelski S; Konopka L; Kotelba-Witkowska B; Rechowicz K; Blaszczyk J Pol Tyg Lek; 1967 Oct; 22(43):1649-54. PubMed ID: 6064248 [No Abstract] [Full Text] [Related]
5. [Erythrocyte life span in patients with chronic nonspecific diseases of the lungs]. Tarasov AN Ter Arkh; 1970 Sep; 42(9):59-61. PubMed ID: 5502193 [No Abstract] [Full Text] [Related]
6. [Diagnosis of anemia using radioisotopes]. Kariyone S Rinsho Byori; 1968 Aug; 16(8):622-9. PubMed ID: 5750806 [No Abstract] [Full Text] [Related]
7. [Determination of the life span of Cr 51 -labeled erythrocytes by comparative measurements in vivo and in vitro]. Martinecz V; Szantay I; Cotul S Pediatria (Bucur); 1971; 20(3):249-52. PubMed ID: 5563994 [No Abstract] [Full Text] [Related]
8. [Changes in erythrocyte properties in myocardial infarct according to data from the saponin test and studies with radioactive chromium]. Krylov AA; Tarasov AN Ter Arkh; 1971 Jul; 43(7):37-9. PubMed ID: 5149755 [No Abstract] [Full Text] [Related]
9. [Study of erythrocyte survival in relation to the predominant sites of their destruction in patients with osteomyelosclerosis and myelofibrosis]. Sakhibov IaD; Aripov AIa Ter Arkh; 1968 Apr; 40(4):92-7. PubMed ID: 5740515 [No Abstract] [Full Text] [Related]
10. [Life span and quantity of erythrocytes in circulatory insufficiency in patients with mitral defect (study using Cr51)]. Tarasov AN Ter Arkh; 1969 Jan; 41(1):71-4. PubMed ID: 5374610 [No Abstract] [Full Text] [Related]
11. [Formation and destruction of erythrocytes in patients with rheumatic heart disease (studies with the aid of radioactive chromium)]. Tarasov AN Klin Med (Mosk); 1969 Jul; 47(7):87-90. PubMed ID: 5385097 [No Abstract] [Full Text] [Related]
12. [State of the erythrocyte membranes in patients with chronic diseases of the kidneys]. Kolmakova EV Lab Delo; 1988; (7):11-4. PubMed ID: 2460669 [No Abstract] [Full Text] [Related]
13. [Studies on the life span of erythrocytes in hyper- and hypothyreoses]. Hardt H; Taubert M Med Klin; 1968 Mar; 63(11):408-10. PubMed ID: 5722512 [No Abstract] [Full Text] [Related]
14. [Survival curve of 51-chromium labelled erythrocytes: study of 22 patients with malignant diseases]. Bouchaert A; Ditu S Nucl Med (Stuttg); 1971 Oct; 10(3):205-15. PubMed ID: 5118977 [No Abstract] [Full Text] [Related]
15. Radiochromate RBC survival kinetics in the normal human adult. Tyson JW; Dalrymple GV; Meade JH; Marvin HN J Nucl Med; 1971 Jun; 12(6):302-4. PubMed ID: 4931803 [No Abstract] [Full Text] [Related]
16. [Quantitative and qualitative composition of sterol from fibrinogen and erythrocyte membranes in kidney diseases]. Pyrig LA; Mel'man NIa; Vendt VP; Govseeva NN; Kondrat'eva LG Ter Arkh; 1981; 53(12):75-8. PubMed ID: 7336352 [No Abstract] [Full Text] [Related]
17. The mechanism of anaemia in tropical splenomegaly. Pryor DS Q J Med; 1967 Jul; 36(143):337-56. PubMed ID: 6049766 [No Abstract] [Full Text] [Related]
18. [The use of a new index of erythrocyte sedimentation in the early diagnosis of tumoral diseases]. Pompei A; Belloni L; Viale N Arch Maragliano Patol Clin; 1968; 24(3):305-20. PubMed ID: 5755410 [No Abstract] [Full Text] [Related]
19. Radioisotopes in evaluating erythrocyte disorders of maturation, survival and loss. Goswitz FA J Nucl Med; 1967 May; 8(5):377. PubMed ID: 6032693 [No Abstract] [Full Text] [Related]
20. [Study of erythrocyte survival using Cr51 in patients with stomach cancer]. Tsfasman AZ; Meshine EN Med Radiol (Mosk); 1965 Sep; 10(9):50-4. PubMed ID: 5870436 [No Abstract] [Full Text] [Related] [Next] [New Search]